OpenAI Enters Life Sciences Industry with Startup Acquisition

OpenAI bought biotechnology startup Orchestra Bio to expand its capabilities in medical research and drug development. The acquired software uses autonomous agents to monitor clinical trial timelines and flag project delays, which will be integrated into OpenAI life science initiatives.